Healthcare associated Clostridioides difficile infection in adult surgical and medical patients hospitalized in tertiary hospital in Belgrade, Serbia: a seven years prospective cohort study

References

• Zimlichman E, Henderson D, Tamir O, et al. Health care–associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039–8.
   Google Scholar
• Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the USA. N Engl J Med. 2015;372(9):825–834.
   Google Scholar
• Davies KA, Longshaw CM, Davis GL, et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis. 2014;14(12):1208–1219.
   Google Scholar
• Šuljagić V, Miljković I, Starčević S, et al. Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case-control study. Antimicrob Resist Infect Control. 2017;6:31.
   Google Scholar
• Eze P, Balsells E, Kyaw MH, et al. Risk factors for Clostridium difficile infections-an overview of the evidence base and challenges in data synthesis. J Glob Health. 2017;7(1):010417.
   Google Scholar
• Trifan A, Stanciu C, Girleanu I, et al. Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis. World J Gastroenterol. 2017;23(35):6500–6515.
   Google Scholar
• Forrester JD, Cai LZ, Mbanje C, et al. Clostridium difficile infection in low and middle human development index countries: a systematic review. Trop Med Int Health. 2017;22(10):1223–1232.
   Google Scholar
• Silva-Velazco J, Hull TL, Messick C, et al. Medical versus surgical patients with Clostridium difficile infection: is there any difference? Am Surg. 2016;82(12):1155–1159.
   Google Scholar
• Southern WN, Rahmani R, Aroniadis O, et al. Postoperative Clostridium difficile-associated diarrhea. Surgery. 2010;148(1):24–30.
   Google Scholar
• McDonald LC, Coignard B, Dubberke E, et al.; Clostridium difficile Surveillance Working Group. Recommendations for surveillance of Clostridium difficile–associated disease. Infect Control Hosp Epidemiol. 2007;28(2):140–145.
   Google Scholar
• Kuijper EJ, Coignard B, Tüll P, et al.; Study group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12(Suppl6):2–18. .
   Google Scholar
• McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious diseases society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1–e48.
   Google Scholar
• Chopra T, Neelakanta A, Dombecki C, et al. Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the hospital readmission reduction program. Am J Infect Control. 2015;43(4):314–317.
   Google Scholar
• Olsen MA, Stwalley D, Demont C, et al. Increasing age has limited impact on risk of Clostridium difficile infection in an elderly population. Open Forum Infect Dis. 2018;5(7):ofy160.
   Google Scholar
• The selection and use of essential medicines: report of the WHO Expert Committee, 2017 (including the 20th WHO model list of essential medicines and the 6th WHO model list of essential medicines for children). Geneva: World Health Organization; 2017 (WHO technical report series; no. 1006). Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar
• Craig DGN, Thimappa R, Anand V, et al. Inappropriate utilization of intravenous proton pump inhibitors in hospital practice—a prospective study of the extent of the problem and predictive factors. QJM. 2010;103(5):327–335.
   Google Scholar
• Blot E, Escande MC, Besson D, et al. Outbreak of Clostridium difficile-related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics. J Hosp Infect. 2003;53(3):187–192.
   Google Scholar
• Anand A, Glatt AE. Clostridium difficlle infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis. 1993;17(1):109–113.
   Google Scholar
• Fuereder T, Koni D, Gleiss A, et al. Risk factors for Clostridium difficile infection in hemato-oncological patients: a case control study in 144 patients. Sci Rep. 2016;6:31498.
   Google Scholar
• Brown K, Valenta K, Fisman D, et al. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med. 2015;175(4):626–633.
   Google Scholar
• McDonald C, Killgore G, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353(23):2433–2441.
   Google Scholar
• Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366(9491):1079–1084.
   Google Scholar
• Kurti Z, Lovacs B, Mandel M, et al. Burden of Clostridium difficile infection between 2010 and 2013: trends and outcomes from an academic center in Eastern Europe. World J Gastroenterol. 2015;21(21):6728–6735.
   Google Scholar
• Sintra S, Taverna F, Canha C, et al. Epidemiology of Clostridium difficile infection in Portugal: experience at a tertiary care hospital. Eur J Intern Med. 2019;60:e11–e13.
   Google Scholar
• Dingle K, Didelot X, Quan P, et al. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis. 2017;17(4):411–421. Epub 2017 Jan 25.
   Google Scholar
• Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: uptade of systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(4):881–891.
   Google Scholar
• Perić A, Dragojević- Simić V, Milenković B, et al. Antibiotic consumption and healthcare-associated infections in a tertiary hospital in Belgrade, Serbia from 2011 to 2016. J Infect Dev Ctries. 2018;12(10):855–863.
   Google Scholar
• Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. European Medicines Agency 2019 Mar 11 [cited 2019 Apr 6]. Available from: https://www.ema.europa.eu/en/documents/referral/quinolone-fluoroquinolone-article-31-referral-disabling-potentially-permanent-side-effects-lead_en.pdf
   Google Scholar
• Bouza E, Rodríguez-Créixems M, Alcalá L, et al. Is Clostridium difficile infection an increasingly common severe disease in adult intensive care units? A 10-year experience. J Crit Care. 2015;30(3):543–549.
   Google Scholar
• Micek ST, Schramm G, Morrow L, et al. Clostridium difficile infection: a multicenter study of epidemiology and outcomes in mechanically ventilated patients. Crit Care Med. 2013;41(8):1968–1975.
   Google Scholar
• Watkins R, Mangira C, Muakkassa F, et al. Clostridium difficile infection in trauma, surgery, and medical patients admitted to the intensive care unit. Surg Infect (Larchmt). 2018;19(5):488–493.
   Google Scholar
• Chiang SR, Lai CC, Ho CH, et al. Prolonged mechanical ventilation assistance interacts synergistically with carbapenem for Clostridium difficile infection in critically Ill patients. J Clin Med. 2018;7(8):224.
   Google Scholar
• National Guidelines of Good Clinical Practice Rational Usage of Antibiotics. Ministry of Health of the Republic of Serbia. 2018 [cited 2019 Apr 10]. (in Serbian). Available from: https://www.zdravlje.gov.rs/view_file.php?file_id=527&cache=sr
   Google Scholar
• Yasunaga H, Horiguchi H, Hashimoto H, et al. The burden of Clostridium difficile-associated disease following digestive tract surgery in Japan. J Hosp Infect. 2012;82(3):175–180.
   Google Scholar
• Honda H, Yamazaki A, Sato Y, et al. Incidence and mortality associated with Clostridium difficile infection at a Japanese tertiary care Centre. Anaerobe. 2014;25:5–10.
   Google Scholar
• Magee G, Strauss ME, Thomas SM, et al. Impact of Clostridium difficile-associated diarrhoea on acute care length of stay, hospital costs, and readmission: a multicentre retrospective study of inpatients, 2009–2011. Am J Infect Control. 2015;43(11):1148–1153.
   Google Scholar
• Institute of Public Health of Serbia. “Dr Milan Jovanovic Batut”. Report on the improvement of the quality of work in healthcare institutions of the Republic of Serbia. 2017 [cited 2019 Apr 15]. (In Serbian). Available from: http://www.batut.org.rs/download/izvestaji/Pokazatelji%20kvaliteta%20rada%20zdravstvenih%20ustanova%202016.pdf
   Google Scholar
• Oake N, Taljaard M, van Walraven C, et al. The effect of hospital-acquired Clostridium difficile infection on in-hospital mortality. Arch Intern Med. 2010;170(20):1804–1810.
   Google Scholar
• Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 2009;58(6):403–410.
   Google Scholar
• Reveles KR, Lawson KA, Mortensen EM, et al. National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014. PLoS ONE. 2017;12(12):e0189227.
   Google Scholar
• Shin S, Kim M, Kim M, et al. Evaluation of the X pert Clostridium difficile assay for the diagnosis of Clostridium difficile infection. Ann Lab Med. 2012;32(5):355–358.
   Google Scholar
• Swindells J, Brenwald N, Reading N, et al. Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol. 2010;48(2):606–608.
   Google Scholar
• Crobach MJ, Planche T, Eckert C, et al. European society of clinical microbiology and infectious diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016;22(Suppl 4):S63–81.
   Google Scholar